Atlas Trials

Curis, Inc.

13 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Curis, Inc.

RecordFirmDate
A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell Malignancies (NCT07271667)Curis, Inc.2026-04-23
Phase 1 Study of CI-8993 Anti-VISTA Antibody in Patients With Advanced Solid Tumor Malignancies (NCT04475523)Curis, Inc.2020-09-22
Dose Escalation/ Expansion Study of CA-4948 as Monotherapy in Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS) (NCT04278768)Curis, Inc.2020-07-06
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL) (NCT03328078)Curis, Inc.2017-12-28

Track Curis, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.